Richard P. Dealy
Known title: DirectorCIK: 0001121919
Associated companies
Transaction History
| CMP | ▲ Buy | Grant | 1,333 | $0 | 9/30/2026 | View on chart |
| CMP | ▲ Buy | Grant | 944 | $0 | 6/30/2026 | View on chart |
| CMP | ▲ Buy | Grant | 1,259 | $0 | 3/31/2026 | View on chart |
| CMP | ▲ Buy | Option Exercise | 11,905 | $0 | 3/5/2026 | View on chart |
| CMP | ▲ Buy | Grant | 1,496 | $0 | 12/31/2025 | View on chart |
| CMP | ▲ Buy | Grant | 1,530 | $0 | 9/30/2025 | View on chart |
| CMP | ▲ Buy | Grant | 1,463 | $0 | 6/30/2025 | View on chart |
| CMP | ▲ Buy | Grant | 3,163 | $0 | 3/31/2025 | View on chart |
| CMP | ▲ Buy | Option Exercise | 5,685 | $0 | 3/5/2025 | View on chart |
| CMP | ▲ Buy | Grant | 2,612 | $0 | 12/31/2024 | View on chart |
| CMP | ▲ Buy | Grant | 2,444 | $0 | 9/30/2024 | View on chart |
| CMP | ▲ Buy | Grant | 2,844 | $0 | 6/28/2024 | View on chart |
| CMP | ▲ Buy | Grant | 1,830 | $0 | 3/31/2024 | View on chart |
| CMP | ▲ Buy | Option Exercise | 2,989 | $0 | 2/15/2024 | View on chart |
| CMP | ▲ Buy | Grant | 1,037 | $0 | 12/31/2023 | View on chart |
| CMP | ▲ Buy | Grant | 940 | $0 | 9/30/2023 | View on chart |
| CMP | ▲ Buy | Grant | 773 | $0 | 6/30/2023 | View on chart |
| CMP | ▲ Buy | Option Exercise | 2,080 | $0 | 5/9/2023 | View on chart |
| CMP | ▲ Buy | Grant | 766 | $0 | 3/31/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Compass Minerals Reports Q3 2026 Earnings
Compass Minerals released its third-quarter 2026 earnings call transcript. The company currently trades with a high trailing P/E ratio of 50.9, which is notably above the average analyst target price of $29.50. With the stock sitting near its support level of $29.03, investors are likely watching how the market reacts to the latest financial results.
Compass Minerals Reports Q3 2026 Earnings. Compass Minerals released its third-quarter 2026 earnings call transcript. The company currently trades with a high trailing P/E ratio of 50.9, which is notably above the average analyst target price of $29.50. With the stock sitting near its support level of $29.03, investors are likely watching how the market reacts to the latest financial results.